118 related articles for article (PubMed ID: 32694578)
1. TIMP-3 facilitates binding of target metalloproteinases to the endocytic receptor LRP-1 and promotes scavenging of MMP-1.
Carreca AP; Pravatà VM; Markham M; Bonelli S; Murphy G; Nagase H; Troeberg L; Scilabra SD
Sci Rep; 2020 Jul; 10(1):12067. PubMed ID: 32694578
[TBL] [Abstract][Full Text] [Related]
2. Effects of C-reactive protein on the expression of matrix metalloproteinases and their inhibitors via Fcγ receptors on 3T3-L1 adipocytes.
Nakai K; Tanaka H; Yamanaka K; Takahashi Y; Murakami F; Matsuike R; Sekino J; Tanabe N; Morita T; Yamazaki Y; Kawato T; Maeno M
Int J Med Sci; 2017; 14(5):484-493. PubMed ID: 28539825
[TBL] [Abstract][Full Text] [Related]
3. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.
Raeeszadeh-Sarmazdeh M; Do LD; Hritz BG
Cells; 2020 May; 9(5):. PubMed ID: 32466129
[TBL] [Abstract][Full Text] [Related]
4. Entropy increases from different sources support the high-affinity binding of the N-terminal inhibitory domains of tissue inhibitors of metalloproteinases to the catalytic domains of matrix metalloproteinases-1 and -3.
Wu Y; Wei S; Van Doren SR; Brew K
J Biol Chem; 2011 May; 286(19):16891-9. PubMed ID: 21454617
[TBL] [Abstract][Full Text] [Related]
5. Homotrimeric MMP-9 is an active hitchhiker on alpha-2-macroglobulin partially escaping protease inhibition and internalization through LRP-1.
Serifova X; Ugarte-Berzal E; Opdenakker G; Vandooren J
Cell Mol Life Sci; 2020 Aug; 77(15):3013-3026. PubMed ID: 31642940
[TBL] [Abstract][Full Text] [Related]
6. The invariant chain CD74 protein is a cell surface binding partner of TIMP-1 in breast cancer cells.
Høeberg M; Noer JB; Vistesen MV; Bartels A; Bech EM; Nygård SB; Lademann U; Stenvang J; Liu S; Fuglsang AT; Brünner N; Moreira JMA
Mol Oncol; 2023 Aug; 17(8):1595-1612. PubMed ID: 37081824
[TBL] [Abstract][Full Text] [Related]
7. MMPs and ADAMs in neurological infectious diseases and multiple sclerosis.
Muri L; Leppert D; Grandgirard D; Leib SL
Cell Mol Life Sci; 2019 Aug; 76(16):3097-3116. PubMed ID: 31172218
[TBL] [Abstract][Full Text] [Related]
8. Structure and computation-guided yeast surface display for the evolution of TIMP-based matrix metalloproteinase inhibitors.
Shoari A; Khalili-Tanha G; Coban MA; Radisky ES
Front Mol Biosci; 2023; 10():1321956. PubMed ID: 38074088
[TBL] [Abstract][Full Text] [Related]
9. Review: Mechanisms of TIMP-3 accumulation and pathogenesis in Sorsby fundus dystrophy.
Betts JHJ; Troeberg L
Mol Vis; 2024; 30():74-91. PubMed ID: 38601018
[TBL] [Abstract][Full Text] [Related]
10. A New Affinity-Based Probe to Profile MMP Active Forms.
Malgorn C; Becher F; Bruyat P; Fruchart-Gaillard C; Beau F; Bregant S; Devel L
Methods Mol Biol; 2024; 2747():29-39. PubMed ID: 38038929
[TBL] [Abstract][Full Text] [Related]
11. The TIMP protein family: diverse roles in pathophysiology.
Coates-Park S; Rich JA; Stetler-Stevenson WG; Peeney D
Am J Physiol Cell Physiol; 2024 Mar; 326(3):C917-C934. PubMed ID: 38284123
[TBL] [Abstract][Full Text] [Related]
12. Tracing the evolution of tissue inhibitor of metalloproteinases in Metazoa with the
Ma CY; Chen Y; Zhan X; Dong YW
iScience; 2024 Jan; 27(1):108579. PubMed ID: 38161420
[TBL] [Abstract][Full Text] [Related]
13. High-Affinity Binding of LDL Receptor-Related Protein 1 to Matrix Metalloprotease 1 Requires Protease:Inhibitor Complex Formation.
Arai AL; Migliorini M; Au DT; Hahn-Dantona E; Peeney D; Stetler-Stevenson WG; Muratoglu SC; Strickland DK
Biochemistry; 2020 Aug; 59(32):2922-2933. PubMed ID: 32702237
[TBL] [Abstract][Full Text] [Related]
14. lncTIMP3 promotes osteogenic differentiation of bone marrow mesenchymal stem cells via miR-214/Smad4 axis to relieve postmenopausal osteoporosis.
Wumiti T; Wang L; Xu B; Ma Y; Zhu Y; Zuo X; Qian W; Chu X; Sun H
Mol Biol Rep; 2024 Jun; 51(1):719. PubMed ID: 38824271
[TBL] [Abstract][Full Text] [Related]
15. ADAM10-a "multitasker" in sepsis: focus on its posttranslational target.
Liao S; Lin Y; Liu L; Yang S; Lin Y; He J; Shao Y
Inflamm Res; 2023 Mar; 72(3):395-423. PubMed ID: 36565333
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal RNA Sequencing of Skin and DRG Neurons in Mice with Paclitaxel-Induced Peripheral Neuropathy.
Cirrincione AM; Reimonn CA; Harrison BJ; Rieger S
Data (Basel); 2022 Jun; 7(6):. PubMed ID: 36248261
[TBL] [Abstract][Full Text] [Related]
17. The Repertoire of Tissue Inhibitors of Metalloproteases: Evolution, Regulation of Extracellular Matrix Proteolysis, Engineering and Therapeutic Challenges.
Costa S; Ragusa MA; Lo Buglio G; Scilabra SD; Nicosia A
Life (Basel); 2022 Jul; 12(8):. PubMed ID: 36013323
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the Causal Effects of TIMP-3 on Ischaemic Stroke and Intracerebral Haemorrhage: A Mendelian Randomization Study.
Xiao L; Zou X; Liang Y; Wang Y; Zeng L; Wu J
Front Genet; 2022; 13():838809. PubMed ID: 35444693
[No Abstract] [Full Text] [Related]
19. Unravelling the distinct biological functions and potential therapeutic applications of TIMP2 in cancer.
Peeney D; Liu Y; Lazaroff C; Gurung S; Stetler-Stevenson WG
Carcinogenesis; 2022 Jun; 43(5):405-418. PubMed ID: 35436325
[TBL] [Abstract][Full Text] [Related]
20. Tissue Inhibitor of Metalloproteases 3 (TIMP-3): In Vivo Analysis Underpins Its Role as a Master Regulator of Ectodomain Shedding.
Spanò DP; Scilabra SD
Membranes (Basel); 2022 Feb; 12(2):. PubMed ID: 35207132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
